Cardiology

New CMAJ study suggests that telmisartan or valsartan may be the preferred angiotensin receptor blockers for preventing cardiovascular events in patients with diabetes.

Analysis included studies that compared new oral anticoagulants to standard care; all studies had to include data on bleeding events.

Physicians should reconsider the role of the drug in the wake of negative trials, researcher says

Screening for risk factors is not optimal

New cholesterol-reducing probiotic marketed as a natural health product.

High intake linked with lower chronic renal disease risk

The incidence of PE in Canada has increased significantly due to the widespread availability and sensitivity of equipment used to diagnose this illness.

High intake linked with lower chronic renal disease risk